Monday, May 20, 2013

• Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic DiseasesPR Newswire( (Mon, May 20)

Wednesday, May 15, 2013

• Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-TPR Newswire( (Wed, May 15)

Thursday, May 9, 2013

• Sangamo BioSciences Announces Presentation at the Bank of America Merrill Lynch 2013 Health Care ConferencePR Newswire( (Thu, May 9)

Wednesday, May 8, 2013

• Sangamo BioSciences Reports First Quarter 2013 Financial ResultsPR Newswire( (Wed, May 8)

Wednesday, May 1, 2013

• Sangamo BioSciences Announces First Quarter 2013 Conference Call and WebcastPR Newswire( (Wed, May 1)

Wednesday, April 24, 2013

• Sangamo BioSciences Announces Presentation At The Needham Healthcare ConferencePR Newswire( (Wed, Apr 24)

Wednesday, April 10, 2013

• Sangamo BioSciences Announces Presentation At Regen Med Investor DayPR Newswire( (Wed, Apr 10)

Wednesday, March 6, 2013

• Sangamo Presents New Clinical Data at CROI 2013 Demonstrating Persistent Immune System Improvements After Treatment With ZFN Therapeutic® SB-728-TPR Newswire( (Wed, Mar 6)

Tuesday, March 5, 2013

• Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare ConferencePR Newswire( (Tue, Mar 5)

Thursday, February 28, 2013

• U.S. Food and Drug Administration Approved 30% More Drugs in 2012Marketwired( (Thu, Feb 28)

Wednesday, February 27, 2013

• Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care ConferencePR Newswire( (Wed, Feb 27)

Thursday, February 7, 2013

• Sangamo BioSciences Announces Presentations At Upcoming Investor ConferencesPR Newswire( (Thu, Feb 7)

Wednesday, February 6, 2013

• Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial ResultsPR Newswire( (Wed, Feb 6)